Tafenoquine in Patients With Mild to Moderate COVID-19
Public ClinicalTrials.gov record NCT04533347. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Oral Tafenoquine Versus Placebo in Patients With Mild to Moderate COVID-19 Disease
Study identification
- NCT ID
- NCT04533347
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- 60 Degrees Pharmaceuticals LLC
- Industry
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Interventions
- Tafenoquine Oral Tablet Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 18, 2021
- Primary completion
- Jun 29, 2022
- Completion
- Jun 29, 2022
- Last update posted
- Jan 6, 2025
2021 – 2022
United States locations
- U.S. sites
- 10
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Deluxe Health Center LLC | Miami | Florida | 33014 | — |
| Hope Clinical Trials | Miami | Florida | 33165 | — |
| F&T Medical Research, Inc. | Miami | Florida | 33184 | — |
| Kendall South Medical Center, Inc. | Miami | Florida | 33185 | — |
| Skyline Medical Center | Elkhorn | Nebraska | 68022 | — |
| Burke Primary Care | Morgantown | North Carolina | 28655 | — |
| AFC Urgent Care | Easley | South Carolina | 29640 | — |
| Centex Studies | Brownsville | Texas | 78526 | — |
| Care United | Forney | Texas | 75126 | — |
| Clinical Trial Network | Houston | Texas | 77074 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04533347, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04533347 live on ClinicalTrials.gov.